EGFR and lung adenocarcinoma: Although paraneoplastic thrombocytosis is reported to be poor prognostic factor in many types of cancer including lung cancer [22,23], platelet count was not prognostic in EGFR-mutant lung adenocarcinoma treated with EGFR-TKI.